|
| CASE REPORT |
 |
|
|
| Year : 2021 |
Volume
: 32 | Issue : 2 | Page
: 579-583 |
|
Coronavirus disease 2019 infection in kidney transplant recipients: A clinical case series
Masoumeh Asgharpour1, Zeinab Mohseni Afshar2, Soheil Ebrahimpour3, Arefeh Babazadeh3, Sahar Oladzad4
1 Department of Nephrology, Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran
2 Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
3 Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
4 Department of Radiology, Mazandaran University of Medical sciences, Sari, Iran
Correspondence Address:
Arefeh Babazadeh
Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol
Iran
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1319-2442.335475
|
|
|
Kidney transplant recipients appear to be at increased risk for severe coronavirus disease 2019 (COVID-19) illness due to some factors such as comorbidities and chronic immunosuppression. Here, we report four cases of COVID-19 infection in kidney transplant recipients. The one case in this series with the high D-dimer levels and receiving tacrolimus had the worst outcome among reported patients. Other patients had better outcomes that probably due to the effect of immunosuppressive therapy in the prevention of COVID-19-induced cytokine storm. It was suggested that a high D-dimer level occurred in critical patients and likely prognostic and also, the immunosuppressive effect of some treatment regimens.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
|
|
